Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Thomas Jefferson University
Thomas Jefferson University
Thomas Jefferson University
University of Arizona
University of Chicago
University of Chicago
University of Chicago
Wake Forest University Health Sciences
Institut Bergonié
University of Chicago
Assiut University
Ohio State University Comprehensive Cancer Center
Roswell Park Cancer Institute
Virginia Commonwealth University
Mayo Clinic